Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with Type 2 Diabetes Mellitus as per the following laboratory parameters. Fasting Blood Sugar ranging 126 to 200 mg per dl Postprandial Blood Sugar ranging 200 to 300 mg per dl. HbA1c ranging from 6.5 to 8 percent. Patients willing to give written consent for participating in the study. Patients who can understand English, Hindi,Bengali. Patients currently on diabetic medication who are recently diagnosed ( less than 6 months) that can be safely discontinued without immediate risk and patients with no history of severe hyperglycemia, diabetic ketoacidosis, or other serious complications.
Exclusion criteria
Exclusion criteria: Presence of severe diabetic complications (retinopathy, nephropathy, cardiovascular disease). Current insulin therapy or participation in other clinical trials. Patients with severe systemic illness, immunocompromised conditions, or significant psychological disorders will be excluded. Pregnancy or lactation. Patients not willing to undergo any investigation, even after advised.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in HbA1cTimepoint: Baseline to 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse events during the study. Change in FBS and PPBS levels Timepoint: Baseline to 3 months and 6 months. | — |
Countries
India
Contacts
National Institute of Homoeopathy